Health Care: Drugs

Emergent BioSolutions Inc (EBS: NYSE)

$28.1 n/a | n/a%
09/26/16 - 04:02 PM ET
Company Profile
Price and Volume
Recent Price 28.10
52 Week High 41.91
52 Week Low 25.51
Avg. Daily Vol. (Mil) 0.54
Beta (3 year) 1.32
Share Related Items
Mkt Cap (Mil) 1,136.89
Shares Out (Mil) 40.46
Float (Mil) 32.25
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.60
Current Ratio 5.80
LT Debt/ Equity 0.37
Total Debt / Equity 0.37
Valuation Ratios
Price Earnings 14.60
Price/Sales 1.99
Price/Book 1.70
Price/Cash Flow 9.20
Per Share Data
Earnings 1.93
Sales 14.09
Book Value 16.49
Cash Flow 3.07
Business Summary
Emergent BioSolutions Inc is a specialty biopharmaceutical company It develops, manufactures, and delivers a portfolio of medical countermeasures for government agencies in the areas of biological and chemical threats and emerging infectious diseases.
General Information
400 Professional Drive
Suite 400
Gaithersburg, MD 20879
Industry : Drugs
Sector: Health Care
Employees: 1292
CEO: Daniel J. Abdun-Nabi
Short Interest
Current Month (Mil) 4.39
Previous Month (Mil) 4.46
Short Interest Ratio (Days) 10.40
Management Effectiveness
Return on Equity 13.30
Return on Assets 8.50
Return on Investments 9.70
Gross Margin 82.70
EBIT Margin 23.40
Profit Margin 15.50

Portfolios with EBS

Latest EBS Headlines from TheStreet

More Financial News for EBS

Press Releases for EBS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter